Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A43237 | 32219876 | Hepatology | Reply. | 2020 | Details |
| A43242 | 32199879 | Gastroenterology | Clinical and Genetic Markers of Nonalcoholic Fatty Liver Disease and Prediction of Liver Disease Mortality: Ready for Population Screening? | 2020 | Details |
| A43251 | 32171039 | Hepatology | MER Proto-Oncogene Tyrosine Kinase: A Novel Potential Target to Treat Nonalcoholic Steatohepatitis Fibrosis. | 2020 | Details |
| A43256 | 32140493 | Hepatobiliary Surg Nutr | Independent regulation of tumorigenesis and fibrosis in non-alcoholic fatty liver disease. | 2020 | Details |
| A43262 | 32122723 | J Hepatol | β-arrestin: Dr Jekyll and Mr Hyde in NASH and fibrosis. | 2020 | Details |
| A43267 | 32118004 | Front Med (Lausanne) | Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients. | 2020 | Details |
| A43283 | 32070159 | J Int Med Res | Improvement in liver stiffness measurement for diagnosis of liver fibrosis in patients with concurrent chronic hepatitis B and nonalcoholic fatty liver disease. | 2020 | Details |
| A43287 | 32061110 | J Pineal Res | Melatonin and circadian rhythms in liver diseases: Functional roles and potential therapies. | 2020 | Details |
| A43289 | 32057684 | Dig Liver Dis | Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologist. | 2020 | Details |
| A43293 | 32043611 | Hepatology | Letter to the Editor: Quantitative Histological Assessment in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A43294 | 32043278 | Hepatology | Reply. | 2020 | Details |
| A43300 | 32027859 | Lancet Gastroenterol Hepatol | Decision making for liver biopsy in NASH, not so FAST? | 2020 | Details |
| A43302 | 32025609 | Hepatol Commun | Tolloid-Like 1 Negatively Regulates Hepatic Differentiation of Human Induced Pluripotent Stem Cells Through Transforming Growth Factor Beta Signaling. | 2020 | Details |
| A43315 | 31992509 | Clin Res Hepatol Gastroenterol | Transient elastography for assessment of fibrosis and steatosis of liver grafts from brain-death donors. | 2020 | Details |
| A43318 | 31984804 | Expert Opin Investig Drugs | NASH and NAFLD: emerging drugs, therapeutic targets and translational and clinical challenges. | 2020 | Details |
| A43322 | 31979912 | J Assoc Physicians India | Correlation of Fibroscan with FIB-4 index and APRI for Assessment of Liver Fibrosis in patients with Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A43325 | 31979905 | J Assoc Physicians India | APRI score: A screening marker of hepatic fibrosis in NAFLD patients. | 2020 | Details |
| A43328 | 31979861 | J Assoc Physicians India | Elastography Compared To APRI, FIB-4 And AST/ ALT Ratio For Assessment Of Liver Fibrosis In Non- Alcoholic Fatty Liver Disease Patients. | 2020 | Details |
| A43342 | 31952447 | Expert Opin Investig Drugs | Targeting CCR2/5 in the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis: opportunities and challenges. | 2020 | Details |
| A43345 | 31937400 | Clin Gastroenterol Hepatol | Daily Aspirin Use Associated With Reduced Risk for Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A43346 | 31933631 | Gastroenterol Res Pract | Liver Stiffness, Not Fat Liver Content, Predicts the Length of QTc Interval in Patients with Chronic Liver Disease. | 2019 | Details |
| A43390 | 31850659 | Liver Int | Author response: Non-alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle-aged adults: The Framingham study. | 2019 | Details |
| A43393 | 31850556 | Aliment Pharmacol Ther | Editorial: blood biomarkers for advanced liver fibrosis in non-alcoholic fatty liver disease-not a simple choice? | 2020 | Details |
| A43394 | 31849080 | Hepatology | Letter to the Editor: Consider More Factors When Studying Risk of Cirrhosis and Hepatocellular Cancer in Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A43406 | 31812989 | Alcohol Alcohol | Associations of Liver Disease with Alcohol Use among People Living with HIV and the Role of Hepatitis C: The New Orleans Alcohol Use in HIV Study. | 2020 | Details |
| A43417 | 31781941 | J Gastroenterol | Is metabolic syndrome responsible for the progression from NAFLD to NASH in non-obese patients? | 2019 | Details |
| A43431 | 31732172 | J Neurol Sci | Response to letter to the editor by Kawada on "Association between nonalcoholic fatty liver disease with advanced fibrosis and stroke". | 2019 | Details |
| A43433 | 31727327 | J Neurol Sci | Nonalcoholic fatty liver disease with advanced fibrosis, stroke and cardiovascular disease. | 2019 | Details |
| A43434 | 31722058 | Dig Dis Sci | Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C. | 2019 | Details |
| A43446 | 31694146 | Nutrients | Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk. | 2019 | Details |
| A43453 | 31677320 | Liver Int | Cognitive impairment in patients with nonalcoholic fatty liver disease with liver fibrosis. | 2019 | Details |
| A43469 | 31648031 | Clin Gastroenterol Hepatol | Poor Concordance Between Liver Stiffness and Noninvasive Fibrosis Scores in HIV Infection Without Viral Hepatitis. | 2019 | Details |
| A43473 | 31617122 | Ann Surg Oncol | Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases. | 2019 | Details |
| A43481 | 31603713 | Arch Pathol Lab Med | Fatty Liver Disease: A Practical Approach. | 2019 | Details |
| A43508 | 31559328 | GE Port J Gastroenterol | Mauriac Syndrome: A Rare Hepatic Glycogenosis in Poorly Controlled Type 1 Diabetes. | 2019 | Details |
| A43511 | 31543242 | Clin Gastroenterol Hepatol | Fibrosis Changes in the Placebo Arm of NASH Clinical Trials. | 2019 | Details |
| A43526 | 31520407 | Hepatology | The 20% Rule of NASH Progression: The Natural History of Advanced Fibrosis and Cirrhosis Caused by NASH. | 2019 | Details |
| A43527 | 31519330 | Atherosclerosis | Reply to: "Hepatic fibrosis - and not steatosis - is the main determinant of arterial stiffness in non-alcoholic fatty liver disease". | 2019 | Details |
| A43532 | 31492444 | Atherosclerosis | Hepatic fibrosis - and not steatosis - is the main determinant of arterial stiffness in non-alcoholic fatty liver disease. | 2019 | Details |
| A43534 | 31484056 | Cell Metab | Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A43537 | 31475778 | J Cell Mol Med | Protective role of melatonin in early-stage and end-stage liver cirrhosis. | 2019 | Details |
| A43539 | 31466125 | Hepatology | Elevated Fatty Liver Index as a Risk Factor for All-Cause Mortality in Human Immunodeficiency Virus-Hepatitis C Virus-Coinfected Patients (ANRS CO13 HEPAVIH Cohort Study). | 2020 | Details |
| A43541 | 31464785 | Eur J Gastroenterol Hepatol | Transient elastography for assessing severe hepatic fibrosis in diabetic patients with nonalcoholic fatty liver disease: definitions matter. | 2019 | Details |
| A43565 | 31393627 | Hepatology | Letter to the Editor: Re: Noninvasive Tests in Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Critical Insights from STELLAR Trials. | 2020 | Details |
| A43570 | 31381156 | Hepatology | Noninvasive Tests of Liver Fibrosis and Their Combination in Nonalcoholic Fatty Liver Disease: From Selected Patients to Real-Life Populations. | 2019 | Details |
| A43578 | 31359473 | Aliment Pharmacol Ther | Letter: improvement of clinical outcomes by metformin in metabolic liver disease-a microbiota-dependent mechanism? | 2019 | Details |
| A43585 | 31352095 | Clin Gastroenterol Hepatol | Reply. | 2019 | Details |
| A43592 | 31335359 | Am J Gastroenterol | ACG Clinical Guideline: Hereditary Hemochromatosis. | 2019 | Details |
| A43593 | 31335197 | Diabetes Technol Ther | Evolving Management Strategies for Nonalcoholic Fatty Liver Disease-Targeting Primary Care Physicians. | 2019 | Details |
| A43596 | 31319680 | Angiology | The Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases. | 2019 | Details |
| A43599 | 31313369 | Aliment Pharmacol Ther | Letter: use of collagen proportionate area to quantify liver fibrosis and predict clinical outcomes non-alcoholic fatty liver disease-authors' reply. | 2019 | Details |
| A43600 | 31313357 | Aliment Pharmacol Ther | Letter: use of collagen proportionate area to quantify liver fibrosis and predict clinical outcomes in non-alcoholic fatty liver disease. | 2019 | Details |
| A43608 | 31300372 | Clin Res Hepatol Gastroenterol | Pharmacological treatments of the "Fibrotic-NASH": Towards a delivery on time? | 2019 | Details |
| A43614 | 31288553 | Angiology | NFS Is Not a Marker of Nonalcoholic Fatty Liver Disease Per Se: What Is the True Relationship With CAD Complexity? | 2019 | Details |
| A43619 | 31278577 | Eur Radiol | Prospective comparison of transient, point shear wave, and magnetic resonance elastography for staging liver fibrosis. | 2019 | Details |
| A43621 | 31269936 | BMC Med | Assessing the disease burden of non-alcoholic fatty liver disease in the real world - big data and big numbers. | 2019 | Details |
| A43629 | 31252189 | Clin Gastroenterol Hepatol | Daily Aspirin Use Reduces Risk of Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease, Providing New Uses for an Old Drug. | 2019 | Details |
| A43642 | 31229270 | J Hepatol | Referral pathways for NAFLD fibrosis in primary care - No longer a 'needle in a haystack'. | 2019 | Details |
| A43657 | 31168510 | Hepatol Commun | Protective Function of Mitogen-Activated Protein Kinase Phosphatase 5 in Aging- and Diet-Induced Hepatic Steatosis and Steatohepatitis. | 2019 | Details |
| A43668 | 31149289 | Acta Endocrinol (Buchar) | NON-INVASIVE ASSESSMENT OF LIVER STEATOSIS AND FIBROSIS USING TRANSIENT ELASTOGRAPHY AND CONTROLLED ATTENUATION PARAMETER IN TYPE 2 DIABETES PATIENTS. | 2022 | Details |
| A43673 | 31137678 | Int J Mol Sci | Adipokinome Signatures in Obese Mouse Models Reflect Adipose Tissue Health and Are Associated with Serum Lipid Composition. | 2019 | Details |
| A43689 | 31098371 | Hepatobiliary Surg Nutr | Nonalcoholic fatty liver disease with advanced fibrosis as a multi-systemic disease: proceed with caution. | 2019 | Details |
| A43697 | 31087779 | IUBMB Life | Intricate role of yes-associated protein1 in human liver cirrhosis: TGF-β1 still is a giant player. | 2019 | Details |
| A43705 | 31076986 | Dig Dis Sci | Serum and Fecal Oxylipins in Patients with Alcohol-Related Liver Disease. | 2019 | Details |
| A43709 | 31061705 | Clin Liver Dis (Hoboken) | Con: Liver Biopsy Remains the Gold Standard to Evaluate Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A43716 | 31048404 | J Lipid Res | Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorption. | 2019 | Details |
| A43725 | 31020772 | Liver Int | Reading the stars for hepatic fibrosis or how to predict the severity of liver disease in patients with NASH. | 2019 | Details |
| A43727 | 31016744 | Hepatology | Mannose Phosphate Isomerase and Mannose Regulate Hepatic Stellate Cell Activation and Fibrosis in Zebrafish and Humans. | 2019 | Details |
| A43730 | 31008799 | AIDS | Clinical significance of elevated liver transaminases in HIV-infected patients. | 2019 | Details |
| A43736 | 30998192 | Ann Biol Clin (Paris) | [Non-invasive biomarkers of fibrosis for the screening of patients with metabolic steatopathy (NAFLD): a significant role for all biologists]. | 2019 | Details |
| A43740 | 30989998 | Minerva Med | Liver fibrosis: which are independent predictors? | 2019 | Details |
| A43743 | 30988908 | Clin Liver Dis (Hoboken) | Spotlight on Impactful Research: Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systemic Review and Meta-Analysis. | 2018 | Details |
| A43749 | 30968034 | World J Clin Cases | Effects of apoptosis on liver aging. | 2019 | Details |
| A43753 | 30956575 | Proc (Bayl Univ Med Cent) | Testing the ability of the nonalcoholic fatty liver disease fibrosis score to predict 1-year all-cause hospital admission. | 2019 | Details |
| A43754 | 30953755 | Clin Gastroenterol Hepatol | Validation Study of Elastographies in Patients With Nonalcoholic Fatty Liver Disease for Detecting Liver Fibrosis. | 2019 | Details |
| A43758 | 30948353 | EBioMedicine | Nitro-oleic acid as a new drug candidate for non-alcoholic steatohepatitis. | 2019 | Details |
| A43760 | 30947397 | Liver Transpl | Reply. | 2019 | Details |
| A43771 | 30915535 | J Gastroenterol | Is the grade of ballooned hepatocytes a significant risk factor for rapid progression of hepatic fibrosis in patients with NAFLD? | 2019 | Details |
| A43772 | 30915534 | J Gastroenterol | Response to the letter by Sumida et al. regarding our manuscript "Evaluation of ballooned hepatocytes as a risk factor for future progression of fibrosis in patients with non-alcoholic fatty liver disease". | 2019 | Details |
| A43773 | 30912096 | Semin Liver Dis | Endoplasmic Reticulum Stress in Metabolic Liver Diseases and Hepatic Fibrosis. | 2019 | Details |
| A43787 | 30884094 | Liver Transpl | Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis. | 2019 | Details |
| A43788 | 30883822 | Hepatology | Letter to the Editor: Will Vitamin E Be the Hope of Patients With NASH and Advanced Fibrosis? The Reliability Is Worth Discussing. | 2019 | Details |
| A43798 | 30854668 | Hepatology | Reply. | 2019 | Details |
| A43799 | 30852587 | J Infect Dis | Increased Prevalence of Hepatic Steatosis in Young Adults With Lifelong HIV. | 2019 | Details |
| A43800 | 30847693 | Dig Dis Sci | Fat and Fibrosis: Does Empagliflozin Impair the Progression of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus? | 2020 | Details |
| A43809 | 30831126 | Life Sci | The relevance of pyroptosis in the pathogenesis of liver diseases. | 2019 | Details |
| A43816 | 30805080 | Oxid Med Cell Longev | Hydrogen Sulfide as a Novel Regulatory Factor in Liver Health and Disease. | 2019 | Details |
| A43820 | 30791772 | Expert Rev Gastroenterol Hepatol | Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers. | 2019 | Details |
| A43829 | 30767680 | Am J Physiol Gastrointest Liver Physiol | Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful either. | 2019 | Details |
| A43832 | 30763194 | N Engl J Med | Notch and Nonalcoholic Fatty Liver and Fibrosis. | 2019 | Details |
| A43838 | 30741841 | J Clin Gastroenterol | Thirty Years of Lactobacillus rhamnosus GG: A Review. | 2019 | Details |
| A43839 | 30739262 | Hepatol Int | Serum ferritin as a biomarker for NAFLD: ready for prime time? | 2019 | Details |
| A43848 | 30700210 | Br J Biomed Sci | Clinicopathological impact of anti-smooth muscle antibodies in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A43849 | 30689936 | Glycobiology | Hyaluronan histochemistry-a potential new tool to assess the progress of liver disease from simple steatosis to hepatocellular carcinoma. | 2019 | Details |
| A43855 | 30675025 | Nat Rev Gastroenterol Hepatol | Panel of 10 serum metabolites shows promise in the non-invasive detection of advanced fibrosis. | 2019 | Details |
| A43872 | 30630119 | Cell Mol Gastroenterol Hepatol | Deletion of C-C Motif Chemokine Ligand 5 Worsens Invariant Natural Killer T-Cell-Mediated Hepatitis via Compensatory Up-regulation of CXCR2-Related Chemokine Activity. | 2019 | Details |
| A43877 | 30615260 | Liver Int | Insights into paediatric non-alcoholic fatty liver disease from genetic variants. | 2019 | Details |
| A43880 | 30610616 | Arch Pharm Res | Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma. | 2019 | Details |
| A43900 | 30515858 | Hepatology | Refining Noninvasive Diagnostics In Nonalcoholic Fatty Liver Disease: Closing the Gap to Detect Advanced Fibrosis. | 2019 | Details |
| A43905 | 30488630 | Aliment Pharmacol Ther | Editorial: stepwise risk stratification for both F3 and F4 in NAFLD patients-authors' reply. | 2018 | Details |